How Continuous Glucose Monitoring Reports Inform Clinical Decision-Making for Older Adults With Type 2 Diabetes: Mapping Clinical Workflow to Situation Awareness
Authors' conclusion
Continuous glucose monitoring data-compared with A1C alone-provided meaningful, actionable information that improved individualized treatment decisions for older adults with type 2 diabetes. Continuous glucose monitoring data enhanced clinicians' perception, comprehension, and projection across the SA continuum, fostering more confident diagnostic reasoning and safer treatment strategies. These findings inform the design of SA-based clinical decision-support tools to better integrate CGM data, address contextual barriers, and optimize management of older adults with type 2 diabetes.
Study context
- Population
- Clinicians reviewing three simulated older adult T2D cases
- Participants
- 30 clinicians
- Comparison
- Clinician decision-making before vs after reviewing continuous glucose monitoring (CGM) reports
- Outcome
- Use of CGM data in clinical decision-making
- Follow-up
- After CGM data review
Methodological detailssemi-structured interviews, simulated cases, situation awareness framework
- Semi-structured interviews
- Simulated cases
- Situation awareness framework
Main finding
As reported in the abstract
Clinicians incorporating TIR metrics
90%
Clinicians identifying previously unrecognized hypoglycemia or nocturnal patterns
93%
Clinicians modifying original treatment plan (eg, deprescribing SU, adjusting insulin, initiating SGLT2i or GLP-1 RA)
86%
Further findings
Barriers to treatment implementation
- Barriers identified: cost, medication access, housing instability, limited food security
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →